Non‐invasive monitoring and treat‐to‐target approach are cost‐effective in patients with mild–moderate ulcerative colitis - Université de Lorraine Accéder directement au contenu
Article Dans Une Revue Alimentary Pharmacology & Therapeutics (Suppl) Année : 2023

Non‐invasive monitoring and treat‐to‐target approach are cost‐effective in patients with mild–moderate ulcerative colitis

Résumé

There are no data to assess the value associated with a treat-to-target (T2T) strategy based on tight control of mild-moderate ulcerative colitis (UC).
Fichier non déposé

Dates et versions

hal-04168388 , version 1 (21-07-2023)

Identifiants

Citer

Paolo Angelo Cortesi, Gionata Fiorino, Laurent Peyrin-Biroulet, Lorenzo Giovanni Mantovani, Vipul Jairath, et al.. Non‐invasive monitoring and treat‐to‐target approach are cost‐effective in patients with mild–moderate ulcerative colitis. Alimentary Pharmacology & Therapeutics (Suppl), 2023, 57 (5), pp.486-495. ⟨10.1111/apt.17261⟩. ⟨hal-04168388⟩
9 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More